Literature DB >> 22454364

Association of AKI with mortality and complications in hospitalized patients with cirrhosis.

Justin M Belcher1, Guadalupe Garcia-Tsao, Arun J Sanyal, Harjit Bhogal, Joseph K Lim, Naheed Ansari, Steven G Coca, Chirag R Parikh.   

Abstract

UNLABELLED: Acute kidney injury (AKI) is a common and devastating complication in patients with cirrhosis. However, the definitions of AKI employed in studies involving patients with cirrhosis have not been standardized, lack sensitivity, and are often limited to narrow clinical settings. We conducted a multicenter, prospective observational cohort study of patients with cirrhosis and AKI, drawn from multiple hospital wards, utilizing the modern acute kidney injury network (AKIN) definition and assessed the association between AKI severity and progression with in-hospital mortality. Of the 192 patients who were enrolled and included in the study, 85 (44%) progressed to a higher AKIN stage after initially fulfilling AKI criteria. Patients achieved a peak severity of AKIN stage 1, 26%, stage 2, 24%, and stage 3, 49%. The incidence of mortality, general medical events (bacteremia, pneumonia, urinary tract infection), and cirrhosis-specific complications (ascites, encephalopathy, spontaneous bacterial peritonitis) increased with severity of AKI. Progression was significantly more common and peak AKI stage higher in nonsurvivors than survivors (P < 0.0001). After adjusting for baseline renal function, demographics, and critical hospital- and cirrhosis-associated variables, progression of AKI was independently associated with mortality (adjusted odds ratio = 3.8, 95% confidence interval 1.3-11.1).
CONCLUSION: AKI, as defined by AKIN criteria, in patients with cirrhosis is frequently progressive and severe and is independently associated with mortality in a stage-dependent fashion. Methods for earlier diagnosis of AKI and its progression may result in improved outcomes by facilitating targeted and timely treatment of AKI.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22454364      PMCID: PMC3390443          DOI: 10.1002/hep.25735

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  34 in total

Review 1.  Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

Authors:  Francesco Salerno; Alexander Gerbes; Pere Ginès; Florence Wong; Vicente Arroyo
Journal:  Gut       Date:  2007-03-27       Impact factor: 23.059

2.  The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis.

Authors:  Damien du Cheyron; Bruno Bouchet; Jean-Jacques Parienti; Michel Ramakers; Pierre Charbonneau
Journal:  Intensive Care Med       Date:  2005-10-22       Impact factor: 17.440

3.  An assessment of the RIFLE criteria for acute renal failure in hospitalized patients.

Authors:  Shigehiko Uchino; Rinaldo Bellomo; Donna Goldsmith; Samantha Bates; Claudio Ronco
Journal:  Crit Care Med       Date:  2006-07       Impact factor: 7.598

4.  Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome.

Authors:  Aleksander Krag; Søren Møller; Jens H Henriksen; Niels-Henrik Holstein-Rathlou; Fin Stolze Larsen; Flemming Bendtsen
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

Review 5.  Diagnosis, epidemiology and outcomes of acute kidney injury.

Authors:  Sushrut S Waikar; Kathleen D Liu; Glenn M Chertow
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 8.237

Review 6.  Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

Authors:  V Arroyo; P Ginès; A L Gerbes; F J Dudley; P Gentilini; G Laffi; T B Reynolds; H Ring-Larsen; J Schölmerich
Journal:  Hepatology       Date:  1996-01       Impact factor: 17.425

7.  Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis.

Authors:  A Follo; J M Llovet; M Navasa; R Planas; X Forns; A Francitorra; A Rimola; M A Gassull; V Arroyo; J Rodés
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

8.  RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients.

Authors:  Chang-Chyi Jenq; Ming-Hung Tsai; Ya-Chung Tian; Chan-Yu Lin; Chun Yang; Nai-Jen Liu; Jau-Min Lien; Yung-Chang Chen; Ji-Tseng Fang; Pan-Chi Chen; Chih-Wei Yang
Journal:  Intensive Care Med       Date:  2007-06-30       Impact factor: 17.440

9.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

10.  Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis.

Authors:  Vanessa Stadlbauer; Vanessa P Stadlbauer; Gavin A K Wright; Murad Banaji; Ashis Mukhopadhya; Rajeshwar P Mookerjee; Rajeshwar Mookerjee; Kevin Moore; Rajiv Jalan
Journal:  Gastroenterology       Date:  2008-01       Impact factor: 22.682

View more
  102 in total

Review 1.  Bacterial infections in end-stage liver disease: current challenges and future directions.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; Florence Wong; K Rajender Reddy; Patrick S Kamath
Journal:  Gut       Date:  2012-06-03       Impact factor: 23.059

2.  New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection.

Authors:  Florence Wong; Jacqueline G O'Leary; K Rajender Reddy; Heather Patton; Patrick S Kamath; Michael B Fallon; Guadalupe Garcia-Tsao; Ram M Subramanian; Raza Malik; Benedict Maliakkal; Leroy R Thacker; Jasmohan S Bajaj
Journal:  Gastroenterology       Date:  2013-08-30       Impact factor: 22.682

Review 3.  Treatment and management of ascites and hepatorenal syndrome: an update.

Authors:  Kurt Lenz; Robert Buder; Lisbeth Kapun; Martin Voglmayr
Journal:  Therap Adv Gastroenterol       Date:  2015-03       Impact factor: 4.409

Review 4.  Renal impairment in cirrhosis unrelated to hepatorenal syndrome.

Authors:  Gavin Low; Graeme Jm Alexander; David J Lomas
Journal:  Can J Gastroenterol Hepatol       Date:  2015-04-15

Review 5.  GFR Estimating Equations and Liver Disease.

Authors:  Tomasz Beben; Dena E Rifkin
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

6.  Fractional excretion of urea: A simple tool for the differential diagnosis of acute kidney injury in cirrhosis.

Authors:  Kavish R Patidar; Le Kang; Jasmohan S Bajaj; Daniel Carl; Arun J Sanyal
Journal:  Hepatology       Date:  2018-05-17       Impact factor: 17.425

7.  Early Postoperative Neutrophil Gelatinase-Associated Lipocalin Predicts the Development of Chronic Kidney Disease After Liver Transplantation.

Authors:  Giuseppe Cullaro; Joseph F Pisa; Robert S Brown; Gebhard Wagener; Elizabeth C Verna
Journal:  Transplantation       Date:  2018-05       Impact factor: 4.939

8.  The confusion assessment method for the intensive care unit in patients with cirrhosis.

Authors:  Eric S Orman; Anthony Perkins; Marwan Ghabril; Babar A Khan; Naga Chalasani; Malaz A Boustani
Journal:  Metab Brain Dis       Date:  2015-05-07       Impact factor: 3.584

Review 9.  Acute-on-Chronic Liver Failure.

Authors:  Sumeet K Asrani; Douglas A Simonetto; Patrick S Kamath
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-15       Impact factor: 11.382

10.  Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List.

Authors:  Nathalie H Urrunaga; Laurence S Magder; Matthew R Weir; Don C Rockey; Ayse L Mindikoglu
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.